Physician profile
Ashok Kukadia
NPI 1841261732
$9,547.87
in general payments reported to CMS, 2019-2025
44 companies · $2,602 in 2025
The $2,602 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,251 · 2020: $408 · 2021: $578 · 2022: $1,071 · 2023: $1,854 · 2024: $1,784 · 2025: $2,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,872 · Education: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,871.97 |
| Education | $367.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,376.24 | 2019-2025 | Erleada, Akeega, Carvykti |
| Astellas Pharma US INC | $1,159.40 | 2019-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $1,042.99 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $894.68 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $641.92 | 2023-2025 | Orgovyx, Gemtesa |
| Teleflex LLC | $519.91 | 2022-2025 | Urolift, Barrigel |
| Ferring Pharmaceuticals INC. | $448.02 | 2019-2025 | Adstiladrin |
| Abbvie INC. | $307.36 | 2019-2025 | |
| Pfizer INC. | $270.03 | 2019-2025 | |
| Biosense Webster, INC. | $257.90 | 2025 | Carto 3 |
| Myovant Sciences INC. | $251.78 | 2021-2022 | |
| Procept Biorobotics Corporation | $234.63 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Telix Pharmaceuticals | $214.15 | 2024-2025 | Illuccix |
| Progenics Pharmaceuticals, INC. | $177.03 | 2021-2025 | Pylarify |
| Urogen Pharma, INC. | $161.92 | 2024-2025 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashok Kukadia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.